The prospect of predictable and reliable oseteogenesis without the need for secondary bone grafting to treat a wide spectrum of spinal disorders is tremendously appealing. Recombinant human bone morphogenic proteins (rhBMP) have been the subject of extensive basic science, animal, and clinical research as a potential therapeutic modality to promote bony fusion. Animal studies and prospective, randomized clinical trials have demonstrated the efficacy of rhBMPs as an adjunct or substitute to autogenous bone graft in the specific treatment of certain spinal conditions. The future role of rhBMPs in spinal surgery applications remains to be determined and will be dependent upon future investigations evaluating 1) the efficacy in a variety of spinal conditions and environments, 2) the optimal dose and delivery system, 3) the long-term safety profile (immunogenicity, antibody formation), and 4) the cost effectiveness of these therapeutic growth factors.
SteinmannJCHerkowitzHNPseudarthrosis of the spineClin Orthop Relat Res199228480–90
2.
DamienCJParsonsJRBone graft and bone graft substitutes: a review of current technology and applicationsJ Appl Biomater199123187–20810.1002/jab.770020307
3.
SummersBNEisensteinSMDonor site pain from the ilium. A complication of lumbar spine fusionJ Bone Joint Surg Br1989714677–680
4.
YoungerEMChapmanMWMorbidity at bone graft donor sitesJ Orthop Trauma198933192–195
5.
JorgensonSSA prospective analysis of autograft versus allograft in posterolateral lumbar fusion in the same patient. A minimum of 1-year follow-up in 144 patientsSpine19941982048–2053
6.
NugentPJDawsonEGIntertransverse process lumbar arthrodesis with allogeneic fresh-frozen bone graftClin Orthop Relat Res1993287107–111
7.
LindholmTSRagniPLindholmTCResponse of bone marrow stroma cells to demineralized cortical bone matrix in experimental spinal fusion in rabbitsClin Orthop Relat Res1988230296–302
8.
OikarinenJExperimental spinal fusion with decalcified bone matrix and deep-frozen allogeneic bone in rabbitsClin Orthop Relat Res1982162210–218
9.
FinkemeierCGBone-grafting and bone-graft substitutesJ Bone Joint Surg Am200284-A3454–464
10.
UristMRBone: formation by autoinductionScience1965150698893–899
11.
SampathTKBovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamilyJ Biol Chem19902652213198–13205
12.
SampathTKReddiAHDissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiationProc Natl Acad Sci U S A198178127599–7603
13.
Boden SD (1999) Bioactive factors for bone tissue engineering. Clin Orthop Relat Res (367 Suppl):S84–S94
14.
LuytenFPPurification and partial amino acid sequence of osteogenin, a protein initiating bone differentiationJ Biol Chem19892642313377–13380
15.
OzkaynakEOP-1 cDNA encodes an osteogenic protein in the TGF-beta familyEMBO J1990972085–2093
16.
KatagiriTThe non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2Biochem Biophys Res Commun19901721295–29910.1016/S0006-291X(05)80208-6
17.
TakuwaYBone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells MC3T3-E1Biochem Biophys Res Commun1991174196–10110.1016/0006-291X(91)90490-X
18.
YehLCOsteogenic protein-1 regulates insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-5 (IGFBP-5) gene expression in fetal rat calvaria cells by different mechanismsJ Cell Physiol1998175178–8810.1002/(SICI)1097-4652(199804)175:1<78::AID-JCP9>3.0.CO;2-9
19.
YehLCLeeJCOsteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cellsMol Cell Endocrinol19991531–2113–12410.1016/S0303-7207(99)00076-3
20.
YehLCUndaRLeeJCOsteogenic protein-1 differentially regulates the mRNA expression of bone morphogenetic proteins and their receptors in primary cultures of osteoblastsJ Cell Physiol2000185187–9710.1002/1097-4652(200010)185:1<87::AID-JCP8>3.0.CO;2-8
Sandhu H, Kabo JM, Turner AS (1996) rhBMP-2 augmentation of titanium fusion cages for experimental anterior lumbar fusion. Presented at the Annual Meeting of the North American Spine Society
23.
SandhuHSHistologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinal anterior interbody fusionSpine2002276567–57510.1097/00007632-200203150-00003
24.
Zdeblick TA, Heim SE, Kleeman TJ (2001) Laparoscopic approach with tapered metal cages: rhBMP-2 vs. autograft. Presented at the Annual Meeting of the North American Spine Society, 31 Oct–3 Nov, Seattle, WA
25.
BodenSDLaparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cageJ Spinal Disord199811295–101
26.
HechtBPThe use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion modelSpine1999247629–63610.1097/00007632-199904010-00004
27.
SandhuHSEvaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion modelSpine199520242669–2682
28.
SandhuHSEffective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusionSpine199621182115–212210.1097/00007632-199609150-00012
29.
SandhuHSExperimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elementsSpine199722111171–118010.1097/00007632-199706010-00001
30.
FischgrundJSAugmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion modelJ Spinal Disord1997106467–472
31.
SchimandleJHBodenSDHuttonWCExperimental spinal fusion with recombinant human bone morphogenetic protein-2Spine199520121326–1337
32.
MartinGJJrPosterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safetyJ Spinal Disord1999123179–186
33.
BodenSDPosterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primateSpine199924121179–118510.1097/00007632-199906150-00002
34.
SuhDYDelivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primateSpine2002274353–36010.1097/00007632-200202150-00006
35.
Suh DY, Boden SD, Ugbo JL (2002) Use of rhBMP-2 supplemented with allograft bone chips in posterolateral fusions in nonhuman primates. Presented at the Annual Meeting of the American Academy of Orthopaedic Surgeons, Dallas, TX, 13–17 Feb 2002
36.
Minamide A et al (2001) Use of rhBMP-2 supplemented with allograft bone chips in posterolateral fusions in nonhuman primates. Presented at the Annual Meeting of the North American Spine Society, Seattle, WA, 31 Oct–3 Nov 2001
37.
MartinGJJrBodenSDTitusLRecombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusionSpine199924212188–219310.1097/00007632-199911010-00003
38.
BodenSDThe use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary reportSpine2000253376–38110.1097/00007632-200002010-00020
39.
Gornet MF, Burkus K, Dickman CA (2001) rhBMP-2 with tapered cages: a prospective, randomized lumbar fusion study. Presented at the Annual Meeting of the North American Spine Society, Seattle, WA, 31 Oct–3 Nov 2001
40.
BurkusJKAnterior lumbar interbody fusion using rhBMP-2 with tapered interbody cagesJ Spinal Disord Tech2002155337–349
41.
BurkusJKClinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2Spine200227212396–240810.1097/00007632-200211010-00015
42.
BodenSDUse of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studiesSpine200227232662–267310.1097/00007632-200212010-00005
43.
Luque E (2002) Latest clinical results using demineralized bone materials and rhBMP-2: The Mexican experience. Presented at Total Spine: Advanced Concepts and Constructs, Cancun, Mexico
CookSDIn vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusionsSpine199419151655–1663
47.
GrauerJN2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusionSpine2001262127–13310.1097/00007632-200101150-00004
48.
CunninghamBWOsseointegration of autograft versus osteogenic protein-1 in posterolateral spinal arthrodesis: emphasis on the comparative mechanisms of bone inductionSpine J20022111–2410.1016/S1529-9430(01)00170-X
49.
MaginMNDellingGImproved lumbar vertebral interbody fusion using rhOP-1: a comparison of autogenous bone graft, bovine hydroxylapatite (Bio-Oss), and BMP-7 (rhOP-1) in sheepSpine2001265469–47810.1097/00007632-200103010-00009
50.
CunninghamBWOsteogenic protein versus autologous interbody arthrodesis in the sheep thoracic spine. A comparative endoscopic study using the Bagby and Kuslich interbody fusion deviceSpine1999246509–51810.1097/00007632-199903150-00002
51.
Chirossel JP, Gay E, Boutrand JP, et al (2000) Stryker spine PEEK and titanium cages: interbody fusion with OP-1 (BMP-7) vs. autograft in a sheep model. Presented at the EuroSpine meeting, Antwerp, Belgium
52.
PatelTCOsteogenic protein-1 overcomes the inhibitory effect of nicotine on posterolateral lumbar fusionSpine200126151656–166110.1097/00007632-200108010-00004
53.
Speck G (2000) Posterolateral fusion using OP-1: a model using degenerative spondylolisthesis. Presented at the Australian Spine Meeting, Adelaide, Australia
54.
Patel TC, Vaccaro AR, Truumees E et al (2001) A safety and efficacy study of OP-1 (rhBMP-7) as an adjunct to posterolateral lumbar fusion. Presented at the Annual Meeting of the North American Spine Society, Seattle, WA, 31 Oct–3 Nov 2001
55.
Vaccaro AR et al (2005) A 2-Year follow-up pilot study evaluating the safety and efficacy of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J (in press)
56.
VaccaroARA pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesisSpine200429171885–189210.1097/01.brs.0000137062.79201.98
57.
VaccaroARA pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusionsEur Spine J2003125495–50010.1007/s00586-003-0561-8
58.
Sandhu HS, Kanim LE, Dawson ED (1997) The safety and efficacy of purified native human bone morphogenic protein for spinal fusion. A ten-Year follow-up study. Presented at the Annual Meeting of the American Academy of Orthopaedic Surgeons, San Francisco, CA, 13–17 Feb 1997
59.
Le RouxPOP-1 enhances dendritic growth from cerebral cortical neurons in vitroExp Neurol19991601151–16310.1006/exnr.1999.7194
60.
HelderMNExpression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse developmentJ Histochem Cytochem199543101035–1044
61.
SolurshMOsteogenic protein-1 is required for mammalian eye developmentBiochem Biophys Res Commun19962182438–44310.1006/bbrc.1996.0078
62.
OzkaynakEOsteogenic protein-1 mRNA in the uterine endometriumBiochem Biophys Res Commun19972341242–24610.1006/bbrc.1997.6624
63.
PollyDWJrA cost analysis of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusionOrthopedics200326101027–1037
64.
Tim YoonSThe effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitroSpine200328161773–178010.1097/01.BRS.0000083204.44190.34
65.
LiJYoonSTHuttonWCEffect of bone morphogenetic protein-2 (BMP-2) on matrix production, other BMPs, and BMP receptors in rat intervertebral disc cellsJ Spinal Disord Tech2004175423–42810.1097/01.bsd.0000112084.85112.5d
66.
SobajimaSQuantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reactionSpine J20055114–2310.1016/j.spinee.2004.05.251
67.
TakaeRImmunolocalization of bone morphogenetic protein and its receptors in degeneration of intervertebral discSpine199924141397–140110.1097/00007632-199907150-00002
